tiprankstipranks
Trending News
More News >
Linkage Global Inc (LGCB)
NASDAQ:LGCB
US Market

Linkage Global Inc (LGCB) AI Stock Analysis

Compare
44 Followers

Top Page

LGCB

Linkage Global Inc

(NASDAQ:LGCB)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 5.2)
Rating:43Neutral
Price Target:
$1.50
▼(-20.21% Downside)
Action:ReiteratedDate:02/04/26
The score is driven primarily by severe fundamental deterioration (sharp revenue collapse, sustained losses, and negative cash flow). Technicals also remain weak with the stock below all key moving averages and negative MACD, while valuation is constrained by loss-making results (negative P/E) and no dividend support.
Positive Factors
Improved leverage
Material reduction in leverage improves solvency and financial flexibility, lowering near-term refinancing risk and giving management runway to execute strategic shifts. A stronger balance sheet supports investment in growth initiatives and reduces the chance of distress over the next several months.
IP licensing traction
Initial CES-driven licensing revenues demonstrate demand for the company’s IP and a scalable, higher-margin revenue stream. Moving from low-margin trading to IP monetization can structurally improve gross margins and recurring cash generation if sustained and expanded across partners and regions.
Fresh equity financing
A new $2M private placement provides immediate liquidity to fund operations and the push into cross-border sales and IP expansion. Fresh capital lengthens runway, reduces urgent solvency pressure, and allows execution of strategic initiatives without immediate asset sales or debt refinancing.
Negative Factors
Revenue collapse
A nearly complete collapse in revenue destroys scale economics and undermines the core cross-border trading business. Even if new initiatives gain traction, rebuilding sustainable top-line levels is a multi-quarter challenge and raises execution risk for restoring margins and profitability.
Negative cash flow
Persistent negative operating and free cash flow indicate the business is not self-funding and will need ongoing external capital. This cash burn elevates refinancing and dilution risk, constrains investment, and creates a structural vulnerability if revenue recovery stalls.
Share-capital changes/dilution risk
Proposed increases in authorized shares and a potential reverse split signal imminent capital-structure actions that can dilute existing holders, alter voting dynamics, and reflect urgent financing needs. Such structural changes can complicate governance and investor confidence over the medium term.

Linkage Global Inc (LGCB) vs. SPDR S&P 500 ETF (SPY)

Linkage Global Inc Business Overview & Revenue Model

Company DescriptionLinkage Global Inc, through its subsidiaries, operates as a cross-border e-commerce integrated services provider in Japan, Mainland China, and internationally. It provides cross-border product sales; digital marketing services; and e-commerce operation training and software support services. Linkage Global Inc was founded in 2011 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyLinkage Global Inc generates revenue through multiple streams, primarily from the sale of its technology solutions and services, including software licenses, hardware sales, and subscription-based models for ongoing support and maintenance. Additionally, the company earns significant revenue from consulting services aimed at helping organizations implement digital transformation strategies. Key partnerships with major telecommunications firms and technology providers enhance LGCB's offerings, allowing it to bundle services and access new markets. Furthermore, LGCB benefits from government contracts and grants aimed at improving infrastructure and connectivity in underserved areas, which contribute to its overall financial performance.

Linkage Global Inc Financial Statement Overview

Summary
Financial performance is very weak: revenue collapsed (~99% YoY in 2025), profitability deteriorated into significant losses (2023–2025), and operating/free cash flow are negative with a large 2025 outflow. Improved leverage helps, but sustained losses and cash burn dominate.
Income Statement
12
Very Negative
Operating performance deteriorated sharply. Revenue collapsed in 2025 (down ~99% year over year) after already declining in 2023–2024, and profitability swung from modestly profitable in 2021–2022 to significant losses in 2023–2025. While gross margin in 2025 appears high, the company is deeply unprofitable at the operating and net levels, indicating the cost structure is not supported by the current sales base.
Balance Sheet
48
Neutral
Leverage has improved materially over time, with debt-to-equity falling from very high levels in 2021–2022 to relatively modest levels by 2025. However, returns on equity are negative in 2023–2025, reflecting value erosion from sustained losses. The balance sheet is not overly levered in the latest period, but ongoing losses remain the key risk to equity durability.
Cash Flow
14
Very Negative
Cash generation is weak and trending poorly. Operating cash flow and free cash flow are negative in 2023–2025, including a very large outflow in 2025, which raises funding and liquidity pressure if conditions persist. Earlier years (2021–2022) showed positive operating cash flow, but the recent multi-year reversal suggests the business is not currently self-funding.
BreakdownSep 2025Sep 2024Sep 2023Sep 2022Sep 2021
Income Statement
Total Revenue34.18K10.29M12.73M22.03M15.47M
Gross Profit24.49K4.17M1.86M3.70M2.54M
EBITDA-28.54K235.51K-431.75K1.30M914.37K
Net Income-49.40K-439.34K-652.73K1.07M751.67K
Balance Sheet
Total Assets144.57K12.69M10.63M9.08M7.58M
Cash, Cash Equivalents and Short-Term Investments4.97K2.00M1.11M3.69M1.78M
Total Debt26.61K2.94M3.16M3.34M4.24M
Total Liabilities33.96K5.67M7.14M6.34M5.86M
Stockholders Equity110.61K7.02M3.50M2.73M1.73M
Cash Flow
Free Cash Flow-32.56K-1.64M-3.90M687.54K-1.85M
Operating Cash Flow-31.41K-1.64M-3.88M1.17M1.22M
Investing Cash Flow-62.02K-365.43K1.83M743.73K-3.21M
Financing Cash Flow84.20K2.88M-398.39K45.74K2.02M

Linkage Global Inc Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1.88
Price Trends
50DMA
1.66
Negative
100DMA
1.77
Negative
200DMA
2.06
Negative
Market Momentum
MACD
0.03
Negative
RSI
51.11
Neutral
STOCH
54.10
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LGCB, the sentiment is Negative. The current price of 1.88 is above the 20-day moving average (MA) of 1.55, above the 50-day MA of 1.66, and below the 200-day MA of 2.06, indicating a neutral trend. The MACD of 0.03 indicates Negative momentum. The RSI at 51.11 is Neutral, neither overbought nor oversold. The STOCH value of 54.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for LGCB.

Linkage Global Inc Risk Analysis

Linkage Global Inc disclosed 70 risk factors in its most recent earnings report. Linkage Global Inc reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Linkage Global Inc Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
60
Neutral
$19.21M2.0320.64%-0.28%363.27%
49
Neutral
$19.86M15.65-11.43%-12.53%-3.24%
48
Neutral
$16.98M-0.13-58.14%-23.15%62.52%
44
Neutral
$23.58M-0.96-10.64%37.38%
43
Neutral
$18.31M-190.70-37.91%0.62%33.82%
43
Neutral
$42.45M-24.66-88.34%-36.13%-556.93%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
LGCB
Linkage Global Inc
1.64
-0.92
-35.94%
TBHC
Brand House Collective
1.05
-0.25
-19.23%
TLF
Tandy Leather Factory
2.38
0.06
2.59%
MOGU
Mogu
2.43
0.02
0.83%
SBDS
Solo Brands
6.86
-22.27
-76.45%
CGTL
Creative Global Technology Holdings Limited
1.65
-1.62
-49.54%

Linkage Global Inc Corporate Events

Linkage Global Inc. Secures $2 Million Private Placement to Fund Cross-Border Expansion
Feb 19, 2026

On February 18, 2026, Linkage Global Inc. entered into a Securities Purchase Agreement with five non-U.S. investors to sell 4,000,000 Class A ordinary shares at $0.50 per share in a private placement for gross proceeds of $2 million. The transaction, conducted under Regulation S, is expected to close on or before March 17, 2026, with proceeds earmarked for general corporate purposes, including working capital and the expansion of the company’s cross-border sales operations.

Under the agreement, Linkage Global plans to file a registration statement with the U.S. Securities and Exchange Commission within 45 days of the deal date to register the newly issued shares, and aims to have it declared effective within 90 to 120 days of filing, depending on regulatory review. The deal structure, including a lock-up period and subsequent registration, is designed to provide fresh capital while managing market impact and enhancing liquidity for investors once the shares become registered.

The most recent analyst rating on (LGCB) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on Linkage Global Inc stock, see the LGCB Stock Forecast page.

Linkage Global Reshapes Board, Adds Biotech and AI Health Expert Dr. Xunyong Zhou
Feb 18, 2026

On February 10, 2026, the board of Linkage Global Inc approved several changes to its membership, with directors Zhiyong Wu and Ryo Fuyunishiki agreeing to step down from the board effective February 13, 2026, while Fuyunishiki will remain as chief operating officer. The company stated the departures were not due to any disagreement over operations or policies, and simultaneously appointed biotechnology and digital health expert Dr. Xunyong Zhou to the board through the next annual general meeting, signaling a push to strengthen its capabilities in health innovation and AI-enhanced solutions.

Dr. Zhou, a 50-year-old entrepreneur, holds more than 20 patents and has led multiple biotechnology and health technology ventures, including roles at Huakang Biomedical Holdings and Nanjing Hezhen Holding Group. His background in enzyme-based product development, cell therapy, and AI-driven health management is expected to bring specialized expertise and broader industry connections to Linkage Global’s governance as it refines its strategic direction.

The most recent analyst rating on (LGCB) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on Linkage Global Inc stock, see the LGCB Stock Forecast page.

Linkage Global Calls March 6 EGM to Reshape Share Capital and Consider Reverse Split
Feb 13, 2026

Linkage Global Inc has called an extraordinary general meeting of shareholders for March 6, 2026, in Fuzhou, China, with February 6, 2026 set as the record date for holders of its Class A and Class B ordinary shares to vote. The meeting notice and proxy materials were filed with the U.S. Securities and Exchange Commission on February 13, 2026, and outline several capital-structure proposals.

Shareholders will be asked to approve an increase in authorized Class B ordinary shares from 2 million to 12 million and corresponding amendments to the company’s memorandum of association to reflect the larger capital base. The agenda also includes a board-discretionary share consolidation of up to 100 existing shares into one new share within two years, with no fractional shares to be issued and any resulting fractions rounded up, along with authority to adjourn the meeting if additional time is needed to secure sufficient votes.

The most recent analyst rating on (LGCB) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on Linkage Global Inc stock, see the LGCB Stock Forecast page.

Linkage Global Rides CES 2026 Success to Licensing Revenue Milestone and Profitability Outlook
Feb 11, 2026

Linkage Global Inc., a cross-border e-commerce services provider headquartered in Tokyo and listed on Nasdaq as LGCB, develops and monetizes consumer electronics-related intellectual property through partnerships and licensing. Its business model combines cross-border product sales with integrated e-commerce solutions, positioning the company to capitalize on global demand for smart devices and branded collaborations.

On February 10, 2026, Linkage Global reported that a successful showcase at CES 2026 and its IP partnership with premium brand ClickClack drove February sales of 72,000 units of licensed products, yielding $720,000 in patent licensing fees. The ClickClack S7 All-Scenario Headphones, built on Linkage Global’s acoustic algorithms and smart wearable technology, were highlighted as CES standouts, and management indicated that if current sales trends hold, the company expects to reach profitability in the first half of 2026, with March order data due by March 5 to gauge continued traction.

The company emphasized that strong market reception for its smart audio-wearable solutions validates the commercial strength of its IP portfolio. Executives said they are using the CES-driven momentum to expand their licensing model globally, signaling a potential shift toward higher-margin IP monetization within the consumer electronics ecosystem.

The most recent analyst rating on (LGCB) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on Linkage Global Inc stock, see the LGCB Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 04, 2026